Testicular Diseases: Clinical Trials

90 trials for Testicular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed, 11 terminated, 6 recruiting, 6 unknown. 90 Phase 2, 12 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 290Completed 64, Terminated 11, Recruiting 6, Unknown 6, Active not recruiting 2, Withdrawn 1
Phase 112Completed 8, Recruiting 2, Terminated 1, Unknown 1
Phase 33Completed 2, Unknown 1

Follow Testicular Diseases: new trials by email Literature Review of Testicular Diseases trials Research Report on Testicular Diseases

Trials (filtered) newest first · largest first

All 90 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Pedmark® STS - Solid Tumor Malignancies, Testicular Cancer
Phase 1 / Phase 2RecruitingUniversity of Arizona252026-05-182026-06-18
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy - Melanoma, Medullary Thyroid Cancer
Phase 1 / Phase 2RecruitingUniversity of Arizona302025-09-082026-10-06
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Low-dose ASA - Germ Cell Tumor, Testicular Cancer
Phase 2RecruitingWake Forest University Health Sciences352025-08-282026-07-24
A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases
Retroperitoneal Lymph Node Dissection - Testicular Cancer
Phase 2RecruitingWestern University, Canada302025-07-172025-07-20
A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm
CLDN6 CAR-T, CLDN6 RNA-LPX - Testicular Germ Cell Tumor, Extragonadal Germ Cell Tumor
Phase 2WithdrawnBioNTech SE2025-07-012025-07-02
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer
Phase 2CompletedUniversity of Southern California1202025-01-162026-05-06
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Albumin-paclitaxel Injection - Paget Disease, Extramammary, Rhabdomyosarcoma
Phase 2RecruitingFudan University1002024-11-302024-12-20
Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline
Paclitaxel, Bleomycin, Etoposide - Germ Cell Cancer Metastatic
Phase 2RecruitingBlokhin's Russian Cancer Research Center602024-10-012026-10-26
Agnostic Therapy in Rare Solid Tumors
Nivolumab - Urachal Cancer, Parathyroid Carcinoma
Phase 2Active not recruitingInstituto do Cancer do Estado de São Paulo282024-07-162026-10-13
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
Carboplatin, Cisplatin, Etoposide - Seminoma, Testicular Cancer
Phase 2Active not recruitingSwiss Cancer Institute1352019-07-292026-01-20
Short-term Testosterone Replacement in Testicular Cancer Survivors
Androgel (Testosterone gel), Placebo gel - Testicular Cancer
Phase 2CompletedUniversity Medical Center Groningen322018-12-212024-07-30
A Biobehavioral Intervention for Young Men With Testicular Cancer
Goal-Focused Emotion Regulation Therapy (GET), Individual Supportive Psychotherapy (ISP) - Testis Cancer
Phase 2UnknownUniversity of California, Irvine1002018-11-012020-12-19
Avelumab in Refractory Testicular Germ Cell Cancer.
Avelumab - Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal
Phase 2CompletedNational Cancer Institute, Slovakia82017-11-152019-03-05
Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
Durvalumab, Tremelimumab - Germ Cell Tumor
Phase 2TerminatedFondazione IRCCS Istituto Nazionale dei Tumori, Milano362017-02-012021-05-14
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Durvalumab, Tremelimumab, Poly-ICLC - Head and Neck Squamous Cell Carcinoma, Breast Cancer
Phase 1 / Phase 2CompletedLudwig Institute for Cancer Research582016-12-282022-12-02
Study of Testosterone vs Placebo in Testicular Cancer Survivors
Testosterone, Placebos - Metabolic Syndrome, Testicular Cancer
Phase 2 / Phase 3CompletedMikkel Bandak692016-11-012020-03-06
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Veliparib, Gemcitabine, Carboplatin - Testicular Cancer
Phase 2CompletedNational Cancer Institute, Slovakia152016-08-012021-03-03
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer
Phase 2TerminatedNabil Adra182016-03-092019-12-10
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Pembrolizumab - Germ Cell Neoplasms, Testicular Neoplasms
Phase 2TerminatedNasser Hanna, M.D.122016-01-012022-07-11
Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
cabazitaxel - Testicular Cancer
Phase 2TerminatedUniversity Hospital, Akershus142015-06-012024-02-02

Showing 20 of 90. Sign in to see all of them.

Narrower conditions

Testicular Neoplasms (83)  ·  Testicular Germ Cell Tumor (35)  ·  Ovarian Neoplasms (31)  ·  Teratoma (22)  ·  Neuroblastoma (18)  ·  Carcinoma, Embryonal (17)  ·  Endodermal Sinus Tumor (17)  ·  Seminoma (17)  ·  Breast Neoplasms (16)  ·  Burkitt Lymphoma (16)  ·  Carcinoma, Ovarian Epithelial (15)  ·  Lymphoma, Large B-Cell, Diffuse (15)  ·  Neoplasms, Germ Cell and Embryonal (15)  ·  Hodgkin Disease (14)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (14)

Broader conditions

Endocrine System Diseases (90)  ·  Genital Diseases (90)  ·  Genital Diseases, Male (90)  ·  Male Urogenital Diseases (90)  ·  Urogenital Diseases (90)  ·  Gonadal Disorders (89)  ·  Endocrine Gland Neoplasms (87)  ·  Neoplasms by Site (87)  ·  Urogenital Neoplasms (87)  ·  Genital Neoplasms, Male (86)  ·  Neoplasms (79)  ·  Neoplasms by Histologic Type (66)  ·  Female Urogenital Diseases (49)  ·  Female Urogenital Diseases and Pregnancy Complications (49)

Interventions

Carboplatin (20)  ·  Etoposide (18)  ·  Paclitaxel (18)  ·  Filgrastim (17)  ·  Ifosfamide (16)  ·  Cisplatin (15)  ·  Peripheral Blood Stem Cell Transplantation (9)  ·  Bleomycin (7)  ·  Gemcitabine (6)  ·  Thiotepa (5)  ·  etoposide phosphate (5)  ·  pegfilgrastim (5)  ·  Cyclophosphamide (4)  ·  Epirubicin (3)  ·  Granulocyte Colony-Stimulating Factor (3)

Sponsors

Memorial Sloan Kettering Cancer Center (11)  ·  Fred Hutchinson Cancer Center (7)  ·  National Cancer Institute (NCI) (5)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (4)  ·  City of Hope Medical Center (3)  ·  European Organisation for Research and Treatment of Cancer - EORTC (3)  ·  Children's Oncology Group (2)  ·  Masonic Cancer Center, University of Minnesota (2)  ·  Medical Research Council (2)  ·  National Cancer Institute, Slovakia (2)  ·  University of Arizona (2)  ·  University of Southern California (2)  ·  Wake Forest University Health Sciences (2)  ·  AHS Cancer Control Alberta (1)  ·  Abramson Cancer Center at Penn Medicine (1)

Countries

United States (55)  ·  Italy (10)  ·  United Kingdom (7)  ·  Canada (5)  ·  Denmark (5)  ·  France (5)  ·  Germany (5)  ·  Netherlands (4)  ·  Slovakia (4)  ·  Switzerland (4)  ·  Belgium (3)  ·  Norway (3)  ·  Australia (2)  ·  Austria (2)  ·  China (2)

Top investigators

Robert J. Motzer, MD (4)  ·  Andrea Necchi, MD (2)  ·  Brian H. Kushner, MD (2)  ·  Darren Feldman, MD (2)  ·  Gnanamba V. Kondagunta, MD (2)  ·  Jubilee Brown (2)  ·  Alejandro Recio-Boiles, MD (1)  ·  Alessandro M Gianni, MD (1)  ·  Alessandro M. Gianni, MD (1)  ·  Alexander McEwan, MD (1)  ·  Alexandros Papachristofilou, MD (1)  ·  Anastasios Raptis, MD (1)  ·  Andrea Isidori, MD, PhD (1)  ·  Andrea Lenzi, MD (1)  ·  Barry L. Gause, MD (1)

Results publications

PMID 11919245, PMID 15999102, PMID 15999362, PMID 16688776, PMID 17194908, PMID 17290059, PMID 19547919, PMID 19841031, PMID 20194867, PMID 21875697, PMID 24894084, PMID 25001888, PMID 25344361, PMID 26199392, PMID 26838019, PMID 28673265, PMID 29045540, PMID 30232558, PMID 30243800, PMID 30302881, PMID 31532522, PMID 32290859, PMID 32641862, PMID 32692450, PMID 34052929, PMID 34223605, PMID 35514022, PMID 35701334, PMID 37078969, PMID 39265466

NIH funding

P30CA008748 (5), U10CA027469 (3), U10CA180868 (3), P30CA033572 (2), U10CA098543 (2), 2009 (1), 2019 (1), N01CM00071 (1), N01CM62206 (1), P30CA006516 (1), P30CA043703 (1), U01CA062491 (1), U01CA062505 (1), U01CA069856 (1), U01CA069912 (1)